DEA Archived Press Releases

Press Releases before January 20, 2025
296 Results - Showing 31 to 40
PRESS RELEASE

Former Wallingford Doctor Who Sold Opioid Prescriptions for Cash Sentenced to Federal Prison

WALLINGFORD, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that ANATOLY BRAYLOVSKY, 52, of Wallingford, hsa been sentenced by U.S. District Judge Kari A. Dooley in Bridgeport to 90 months of imprisonment, followed by three years of supervised release, for controlled substances and health...
PRESS RELEASE

Dark Web Drug Vendor and Clandestine Lab Manufacturer Sentenced to Prison for Trafficking in Meth and Fentanyl

MIAMI – On May 17, an Orange County, California, resident, Tenzin Orgil, 24, was sentenced to 168 months in federal prison for participating in a drug trafficking enterprise that included the sale of methamphetamine and fentanyl on the dark web, as well as the manufacture of ecstasy (also known as...
PRESS RELEASE

Operation Cash Out Launched Across Colorado, Utah, Wyoming, Montana

DENVER – Fentanyl continues to be the leading cause of death for Americans between the ages of 18 and 45. In 2023, the Drug Enforcement Administration (DEA) seized nationally more than 77 million fentanyl pills and nearly 12,000 pounds of fentanyl powder. Across the DEA Rocky Mountain Field Division –...
PRESS RELEASE

Success For DEA Rocky Mountain Field Division Prescription Drug Take Back Day

Thanks to community members, community partners, volunteers and members of the Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) the 26th National Prescription Drug Take Back Day was again a success. This past Saturday, often in challenging weather, people brought in their unneeded, unwanted or expired prescription medications to dozens...
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Enters 15th Year of Removing Unneeded Medications from Communities

El Paso – Together with its law enforcement partners, the Drug Enforcement Administration will host its 26th National Prescription Drug Take Back Day on Saturday, April 27, from 10 a.m. to 2 p.m. This event aims to remove unneeded prescriptions from homes to help prevent medication misuse by offering anonymous...
PRESS RELEASE

Drug Trafficker Sentenced to More Than 10 Years in Federal Prison

BRIDGEPORT, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that JASON COX, 50, formerly of Bridgeport, Connecticut, and Savannah, Georgia, was sentenced today by U.S. District Judge Victor A. Bolden in New Haven to 125 months of imprisonment, followed by five years of supervised...
PRESS RELEASE

DEA Rocky Mountain Field Division Encourages Prescription Take Back This Saturday

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...
PRESS RELEASE

New Haven Pharmacy and Owner Agree to Pay $120,000 to Settle Controlled Substances Act Allegations

NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Cornerstone Pharmacy, Inc. (doing business as “Whalley Drug”), and its owner, YONG KWON, have entered into...
PRESS RELEASE

Dominican Man Sentenced to 10 Years as Member of Maritime Cocaine-Trafficking Conspiracy

MILWAUKEE, Wis. - John McGarry, Assistant Special Agent in Charge of U.S. Drug Enforcement Administration-Milwaukee and Gregory J. Haanstad, United States Attorney for the Eastern District of Wisconsin, announced that on April 11, 2024, Herlin Hernandez-Trinidad, a/k/a “Rainely” (age: 29) of Miches, Dominican Republic, pled guilty to conspiring to possess...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...